SCHEMBL1640309

SCHEMBL1640309

CC1CN(Cc2ccon2)CCC1n1cnc(-c2ccc(F)cc2)c1-c1ccncn1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 6/20 0.59
CSNK1E P49674 4/20 0.59
MAPK14 Q16539 16/20 0.44
MAPK13 O15264 5/20 0.44
MAPK12 P53778 5/20 0.44
MAPK11 Q15759 5/20 0.44
PRKD3 O94806 2/20 0.39
MAP4K4 O95819 2/20 0.39
PRKACA P17612 2/20 0.39
CSNK1A1 P48729 2/20 0.39
MINK1 Q8N4C8 2/20 0.39
MAP4K5 Q9Y4K4 2/20 0.39
HSPB1 P04792 1/20 0.39
PRKCB P05771 1/20 0.39
PRKCA P17252 1/20 0.39
RIPK2 O43353 1/20 0.39
DYRK3 O43781 1/20 0.39
PRKCG P05129 1/20 0.39
LCK P06239 1/20 0.39
LYN P07948 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1640214 0.93 CSNK1D (0.55) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL1640975 0.88 CSNK1D (0.69) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL1640748 0.88 CSNK1D (0.77) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL1640724 0.87 CSNK1D (0.54) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL1639943 0.87 CSNK1D (0.77) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL1640763 0.81 CSNK1D (0.59) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL1640960 0.80 CSNK1D (0.72) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL15463520 0.78 CSNK1D (0.63) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL1639208 0.78 CSNK1D (0.57) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL15203489 0.78 CSNK1D (0.54) CSNK1DCSNK1EMAPK14MAPK13MAPK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2493876-B1 IMIDAZOLE DERIVATIVES AS CASEIN KINASE INHIBITORS PFIZER (US) 2014-02-12 EP disclosed
US-8518944-B2 Compounds as casein kinase inhibitors PFIZER INC. (US) 2013-08-27 US disclosed
US-20110098272-A1 Novel Compounds As Casein Kinase Inhibitors PFIZER INC 2011-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098272-A1 Novel Compounds As Casein Kinase Inhibitors CSNK1A1, CSNK1A1L, CSNK1G1 CSNK1D 12/4885CSNK1E 5/4885MAPK14 169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.